Erratum: C-peptide is the appropriate outcome measure for type 1 diabetes clinical trials to preserve β-cell function: Report of an ADA workshop, 21-22 October 2001 (Diabetes (2004) 53 (250-264))

J. P. Palmer; G. A. Fleming; C. J. Greenbaum; K. C. Herold; L. D. Jansa; H. Kolb; J. M. Lachin; K. S. Polonsky; P. Pozzilli; J. S. Skyler; M. W. Steffes

doi:10.2337/diabetes.53.7.1934

Erratum: C-peptide is the appropriate outcome measure for type 1 diabetes clinical trials to preserve β-cell function: Report of an ADA workshop, 21-22 October 2001 (Diabetes (2004) 53 (250-264))

J. P. Palmer
, G. A. Fleming
, C. J. Greenbaum
, K. C. Herold
, L. D. Jansa
, H. Kolb
, J. M. Lachin
, K. S. Polonsky
, P. Pozzilli
, J. S. Skyler
, M. W. Steffes

Laboratory Medicine and Pathology

Research output: Contribution to journal › Comment/debate › peer-review

1 Scopus citations

Original language	English (US)
Pages (from-to)	1934
Number of pages	1
Journal	Diabetes
Volume	53
Issue number	7
DOIs	https://doi.org/10.2337/diabetes.53.7.1934
State	Published - Jul 2004

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Publisher link

10.2337/diabetes.53.7.1934

Find It

Find It at U of M Libraries

Cite this

Palmer, J. P., Fleming, G. A., Greenbaum, C. J., Herold, K. C., Jansa, L. D., Kolb, H., Lachin, J. M., Polonsky, K. S., Pozzilli, P., Skyler, J. S., & Steffes, M. W. (2004). Erratum: C-peptide is the appropriate outcome measure for type 1 diabetes clinical trials to preserve β-cell function: Report of an ADA workshop, 21-22 October 2001 (Diabetes (2004) 53 (250-264)). Diabetes, 53(7), 1934. https://doi.org/10.2337/diabetes.53.7.1934

Erratum: C-peptide is the appropriate outcome measure for type 1 diabetes clinical trials to preserve β-cell function: Report of an ADA workshop, 21-22 October 2001 (Diabetes (2004) 53 (250-264)). / Palmer, J. P.; Fleming, G. A.; Greenbaum, C. J. et al.
In: Diabetes, Vol. 53, No. 7, 07.2004, p. 1934.

Research output: Contribution to journal › Comment/debate › peer-review

Palmer, JP, Fleming, GA, Greenbaum, CJ, Herold, KC, Jansa, LD, Kolb, H, Lachin, JM, Polonsky, KS, Pozzilli, P, Skyler, JS & Steffes, MW 2004, 'Erratum: C-peptide is the appropriate outcome measure for type 1 diabetes clinical trials to preserve β-cell function: Report of an ADA workshop, 21-22 October 2001 (Diabetes (2004) 53 (250-264))', Diabetes, vol. 53, no. 7, pp. 1934. https://doi.org/10.2337/diabetes.53.7.1934

@article{2214930a9db54eafba82a362f95543fd,

title = "Erratum: C-peptide is the appropriate outcome measure for type 1 diabetes clinical trials to preserve β-cell function: Report of an ADA workshop, 21-22 October 2001 (Diabetes (2004) 53 (250-264))",

author = "Palmer, \{J. P.\} and Fleming, \{G. A.\} and Greenbaum, \{C. J.\} and Herold, \{K. C.\} and Jansa, \{L. D.\} and H. Kolb and Lachin, \{J. M.\} and Polonsky, \{K. S.\} and P. Pozzilli and Skyler, \{J. S.\} and Steffes, \{M. W.\}",

year = "2004",

month = jul,

doi = "10.2337/diabetes.53.7.1934",

language = "English (US)",

volume = "53",

pages = "1934",

journal = "Diabetes",

issn = "0012-1797",

publisher = "American Diabetes Association Inc.",

number = "7",

}

TY - JOUR

T1 - Erratum

T2 - C-peptide is the appropriate outcome measure for type 1 diabetes clinical trials to preserve β-cell function: Report of an ADA workshop, 21-22 October 2001 (Diabetes (2004) 53 (250-264))

AU - Palmer, J. P.

AU - Fleming, G. A.

AU - Greenbaum, C. J.

AU - Herold, K. C.

AU - Jansa, L. D.

AU - Kolb, H.

AU - Lachin, J. M.

AU - Polonsky, K. S.

AU - Pozzilli, P.

AU - Skyler, J. S.

AU - Steffes, M. W.

PY - 2004/7

Y1 - 2004/7

UR - https://www.scopus.com/pages/publications/3042822067

UR - https://www.scopus.com/pages/publications/3042822067#tab=citedBy

U2 - 10.2337/diabetes.53.7.1934

DO - 10.2337/diabetes.53.7.1934

M3 - Comment/debate

AN - SCOPUS:3042822067

SN - 0012-1797

VL - 53

SP - 1934

JO - Diabetes

JF - Diabetes

IS - 7

ER -

Erratum: C-peptide is the appropriate outcome measure for type 1 diabetes clinical trials to preserve β-cell function: Report of an ADA workshop, 21-22 October 2001 (Diabetes (2004) 53 (250-264))

UN SDGs

Publisher link

Find It

Other files and links

Cite this